Magnite, Inc., together with its subsidiaries, operates an independent omni-channel sell-side advertising platform in the United States and internationally.
FAIL · Does not pass the screen
27.52 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price27.52 USD at the 5 Nov 2026 close
Our value readUndervalued vs our fair value, as of 5 Nov 2026
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.46, read 2026-11-02
Ethical does not pass the values gate
Price27.52 USD
Fair value26.67
Ethical score70.0/100
Value readUndervaluedas of 5 Nov 2026
Our investment reviews on this name
2026-10-18Read Markdown25.32+8.7% to today Accumulation gives way to Markdown first Markdown read since October
2026-10-11Read Accumulation24.84+10.8% to today ✓Markdown gives way to Accumulation first Accumulation read since July
2026-10-02Read Markdown25.31+8.7% to today Markup gives way to Markdown after an 8% rise in 4 weeks
2026-09-05Read Markup23.36+17.8% to today ✓Markdown gives way to Markup after a 23% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Magnite, Inc. holds its Markdown at $27.52. Consolidating, no directional conviction, held for 59 days.
As held on the ledger · 2026-11-05
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 59 days
Price at the screen
$27.52
Valuation
19.99 trailing · 17.24 forward price to earnings
Values screen
FAIL· score 70.0
Beta
2.39
The Workings
Five Screens, Shown in Full
Does not pass. Accounts receivable
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
19.79%
Below 33%
Interest-bearing debt is just 19.8% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
58.63%
Below 49%
Money owed to the company is 58.6% of assets, above the 49% limit.
Fail
Revenue purity
1.78%
Below 5%
Only 1.8% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Magnite,'s business is fine, but its receivables are about 59% of its assets, just over the ~49% line, so it does not pass on the financial screens.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when MGNI's ethical verdict changes
Today MGNI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 5 Nov 2026: it trades at roughly a 15% discount to our $26.67 fair value, 11.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-05 screen. The gold marker is the market price at the same screen. The price runs 3.2% above the base estimate.
Where our models see it going: fair-value estimate $26.67, with a range of $19.01 to $31.69, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Ad Sellers Still Face a Crowded Auction Floor
Every time a website or app loads an ad, the publisher must sell inventory in real time against bigger platforms that control much of the flow. Magnite runs an independent sell side system that lets publishers reach more buyers without relying on the largest gatekeepers. The business clears a clean ethical screen and posts a 22 percent profit margin with 19 percent return on equity.
We pass. Revenue growth sits at only 6 percent, the forward multiple is 15.4 times, and the competitive moat remains unknown. Even with a margin of safety implied by our fair value estimate, the modest top line expansion offers little cushion if advertising spend slows or larger rivals tighten their grip.
Risks centre on cyclical ad budgets and the chance that scale advantages stay with the biggest players. Fifteen analysts call the shares a strong buy, yet the combination of low growth and unclear durability leaves no real opportunity on our terms. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
MGNI trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$22.34+4.0%Entry 17
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-03Markdown$21.49+0.0%Entry 16
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-02Markdown$21.49+0.0%Entry 15
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-11-01Markdown$21.49-6.1%Entry 14
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-31Markdown$22.89+0.0%Entry 13
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-30Markdown$22.89+0.0%Entry 12
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-29Markdown$22.89-3.1%Entry 11
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-28Markdown$23.62+0.0%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 31% above its long-term trend line with momentum reading bearish. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Markdown$23.62-6.7%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 36% above its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter.
2026-10-18Markdown · changed$25.32+1.9%Entry 8
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 1.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 30%. The street (14 analysts) rates it strong buy, with a mean price target of $22. Insiders have been net sellers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
